Full Breakdown
Controversy Surrounds NIH Funding for Bat Research Amid COVID-19 Origins Debate
1/13/2026, 7:30:30 AM
Republican Lawmakers Demand Funding Halt
On January 12, 2026, Senator Joni Ernst (R-Iowa) and Representative Paul Gosar (R-Ariz.) called for the National Institutes of Health (NIH) to cease over $3 million in taxpayer funding for research involving live bats at Colorado State University (CSU). The funding, primarily allocated for “experimental infection studies” on SARS-related coronaviruses, has drawn criticism due to concerns about its potential link to the origins of the COVID-19 pandemic. The lawmakers labeled the research as “sketchy” and expressed fears that it could lead to another pandemic.
The NIH funding includes a $2.2 million grant from the National Institute of Allergy and Infectious Diseases (NIAID) and an additional $1.3 million from a prior grant. The research aims to investigate zoonotic viruses, including SARS and MERS, and involves creating breeding colonies of Jamaican and Egyptian fruit bats in the U.S. Ernst and Gosar argue that such research poses significant risks without clear benefits to public health.
Background and Context
The funding for CSU's bat research has been a contentious issue since its inception, with a total of $12.9 million allocated since 2016. This initiative was initially proposed by CSU microbiology professor Tony Schountz and EcoHealth Alliance vice president Jonathan Epstein in a 2016 paper. Ernst and Gosar's concerns are compounded by the history of EcoHealth's involvement in similar research, which has been scrutinized for its potential ties to the Wuhan Institute of Virology, where the COVID-19 outbreak is believed to have originated.
Official Statements & Responses
In their letter to NIH Director Dr. Jay Bhattacharya, Ernst and Gosar emphasized the need for transparency regarding taxpayer funding for gain-of-function research, which involves genetically altering viruses to enhance their transmissibility. They stated, “Risky research with minimal benefit to the health of the American people... should be done only after an extremely intensive safety review.” The Department of Health and Human Services has since barred EcoHealth from receiving federal funding for five years due to previous misconduct.
A spokesperson for CSU defended the institution, asserting its commitment to safety protocols and stating, “In instances when we have something that occurs outside of normal protocols, we immediately self-report and take immediate actions to address it.”
Criticism & Opposition
Critics of the funding, including White Coat Waste founder Anthony Bellotti, have condemned the continuation of taxpayer support for what they describe as “dangerous bat virus experiments.” They argue that funding such research in the U.S. mirrors the controversial practices that occurred in Wuhan, which many believe contributed to the pandemic.
Conversely, proponents of the research assert that understanding how bats host pathogenic viruses without suffering from disease is crucial for preventing future outbreaks. They argue that halting the funding could hinder vital research that may ultimately benefit public health.
Conflicting Reports & Gaps
While Ernst and Gosar assert that the research could be linked to the COVID-19 outbreak, former NIH officials, including Dr. Anthony Fauci, have consistently maintained that the virus originated from natural spillover events. This discrepancy highlights ongoing debates regarding the origins of COVID-19 and the role of laboratory research in potential outbreaks.
What's Next
The NIH has acknowledged receipt of the lawmakers' letter and will respond directly. As the debate continues, further scrutiny of NIH funding practices and research oversight is anticipated, particularly regarding projects involving zoonotic viruses and potential pandemic risks.
